A detailed history of Carronade Capital Management, LP transactions in Organon & Co. stock. As of the latest transaction made, Carronade Capital Management, LP holds 205,463 shares of OGN stock, worth $4.25 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
205,463
Previous 507,343 59.5%
Holding current value
$4.25 Million
Previous $7.32 Million 47.2%
% of portfolio
0.26%
Previous 0.96%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $4.16 Million - $5.68 Million
-301,880 Reduced 59.5%
205,463 $3.86 Million
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $5.56 Million - $8.79 Million
507,343 New
507,343 $7.32 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.26B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Carronade Capital Management, LP Portfolio

Follow Carronade Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carronade Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Carronade Capital Management, LP with notifications on news.